Cerus Debt to Equity Ratio 2006-2019 | CERS

Current and historical debt to equity ratio values for Cerus (CERS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cerus debt/equity for the three months ending June 30, 2019 was 0.88.
Cerus Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-06-30 $0.06B $0.07B 0.88
2019-03-31 $0.06B $0.07B 0.85
2018-12-31 $0.02B $0.09B 0.26
2018-09-30 $0.02B $0.09B 0.26
2018-06-30 $0.03B $0.09B 0.29
2018-03-31 $0.03B $0.09B 0.33
2017-12-31 $0.03B $0.04B 0.77
2017-09-30 $0.03B $0.04B 0.80
2017-06-30 $0.01B $0.04B 0.30
2017-03-31 $0.01B $0.04B 0.25
2016-12-31 $0.01B $0.06B 0.22
2016-09-30 $0.01B $0.07B 0.20
2016-06-30 $0.01B $0.08B 0.18
2016-03-31 $0.02B $0.08B 0.18
2015-12-31 $0.02B $0.10B 0.18
2015-09-30 $0.02B $0.10B 0.19
2015-06-30 $0.02B $0.11B 0.16
2015-03-31 $0.01B $0.11B 0.09
2014-12-31 $0.01B $0.04B 0.24
2014-09-30 $0.01B $0.05B 0.21
2014-06-30 $0.01B $0.04B 0.22
2014-03-31 $0.00B $0.05B 0.00
2013-12-31 $0.00B $0.04B 0.00
2013-09-30 $0.00B $0.04B 0.00
2013-06-30 $0.00B $0.06B 0.00
2013-03-31 $0.00B $0.06B 0.04
2012-12-31 $0.00B $0.02B 0.15
2012-09-30 $0.00B $0.02B 0.20
2012-06-30 $0.00B $0.02B 0.20
2012-03-31 $0.00B $0.01B 0.42
2011-12-31 $0.01B $0.01B 0.53
2011-09-30 $0.01B $0.01B 0.74
2011-06-30 $0.00B $0.00B 0.58
2011-03-31 $0.00B $0.01B 0.28
2010-12-31 $0.00B $0.01B 0.22
2010-09-30 $0.00B $0.00B 1.28
2010-06-30 $0.00B $0.00B 1.57
2010-03-31 $0.01B $0.01B 0.60
2009-12-31 $0.00B $0.01B 0.00
2009-09-30 $0.00B $0.02B 0.00
2009-06-30 $0.00B $0.01B 0.00
2009-03-31 $0.00B $0.02B 0.00
2008-12-31 $0.00B $0.03B 0.00
2008-09-30 $0.00B $0.03B 0.00
2008-06-30 $0.00B $0.04B 0.00
2008-03-31 $0.00B $0.05B 0.00
2007-12-31 $0.00B $0.05B 0.00
2007-09-30 $0.00B $0.06B 0.00
2007-06-30 $0.00B $0.07B 0.00
2007-03-31 $0.00B $0.09B 0.00
2006-12-31 $0.00B $0.09B 0.00
2006-09-30 $0.00B $0.06B 0.00
2006-06-30 $0.00B $0.07B 0.00
2006-03-31 $0.00B $0.07B 0.00
2005-12-31 $0.00B $0.03B 0.00
2005-09-30 $0.01B 0.00
2005-06-30 $0.01B 0.00
2005-03-31 $0.01B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.627B $0.061B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $146.323B 26.71
Medtronic (MDT) Ireland $145.061B 20.36
Stryker (SYK) United States $80.552B 27.85
Boston Scientific (BSX) United States $53.588B 25.99
Baxter (BAX) United States $44.924B 27.24
EssilorLuxottica Societe Anonyme (ESLOY) France $32.865B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.253B 18.08
Coloplast (CLPBY) Denmark $25.488B 40.69
Lonza Group Ag (LZAGY) Switzerland $25.356B 0.00
Terumo (TRUMY) Japan $24.335B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $20.897B 0.00
ResMed (RMD) United States $18.864B 35.95
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $10.229B 54.83
Insulet (PODD) United States $9.266B 549.07
Perrigo (PRGO) Ireland $7.333B 13.51
Canopy Growth (CGC) Canada $7.030B 0.00
Hill-Rom Holdings (HRC) United States $6.817B 20.33
Haemonetics (HAE) United States $6.460B 48.76
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.344B 27.61
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.786B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.648B 0.00
NuVasive (NUVA) United States $3.463B 27.61
Neogen (NEOG) United States $3.393B 56.77
ICU Medical (ICUI) United States $3.219B 20.88
Quidel (QDEL) United States $2.561B 25.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.550B 0.00
Agios Pharmaceuticals (AGIO) United States $1.943B 0.00
National Vision Holdings (EYE) United States $1.805B 38.97
Cardiovascular Systems (CSII) United States $1.730B 0.00
Aphria (APHA) $1.197B 0.00
VAREX IMAGING (VREX) United States $1.103B 25.42
AtriCure (ATRC) United States $1.057B 0.00
Phibro Animal Health (PAHC) United States $0.853B 13.88
Eagle Pharmaceuticals (EGRX) United States $0.843B 21.50
Omeros (OMER) United States $0.782B 0.00
NanoString Technologies (NSTG) United States $0.760B 0.00
Lantheus Holdings (LNTH) United States $0.732B 19.25
LeMaitre Vascular (LMAT) United States $0.696B 41.24
PetIQ (PETQ) United States $0.676B 15.98
Surmodics (SRDX) United States $0.605B 114.95
MacroGenics (MGNX) United States $0.538B 0.00
Quanterix (QTRX) United States $0.527B 0.00
OraSure Technologies (OSUR) United States $0.523B 24.21
TG Therapeutics (TGTX) United States $0.518B 0.00
Owens & Minor (OMI) United States $0.450B 13.47
Meridian Bioscience (VIVO) United States $0.428B 13.37
Utah Medical Products (UTMD) United States $0.356B 26.11
Zynex (ZYXI) United States $0.340B 36.14
BioLife Solutions (BLFS) United States $0.332B 102.06
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.326B 0.00
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.229B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Repro-Med Systems (REPR) United States $0.163B 0.00
Rockwell Medical (RMTI) United States $0.158B 0.00
Cytosorbents (CTSO) United States $0.146B 0.00
Female Health (VERU) United States $0.140B 0.00
Fonar (FONR) United States $0.130B 9.14
Liberty Health Sciences (LHSIF) Canada $0.106B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
Chimerix (CMRX) United States $0.089B 0.00
United-Guardian (UG) United States $0.085B 20.00
Nephros (NEPH) United States $0.083B 0.00
MTech Acquisition (KERN) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Surface Oncology (SURF) United States $0.037B 0.00
Senestech (SNES) United States $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00